Recursion Pharmaceuticals’ stock plunges 7% after shock Q4 loss – What went wrong?

Recursion Pharmaceuticals, a clinical-stage biotechnology company leveraging artificial intelligence for drug discovery, reported a significantly wider loss for the fourth quarter of 2024. The company’s ... Read More